Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07118215) titled 'A Study to Evaluate the Effects of KarXT on the Drug Levels of Midazolam, Fexofenadine, and Digoxin' on Aug. 5.
Study Type: Interventional
Study Design:
Allocation: Non-Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Karuna Therapeutics
Condition:
Healthy Volunteers
Intervention:
Drug: KarXT
Drug: Midazolam
Drug: Fexofenadine
Recruitment Status: Not recruiting
Phase: Phase 1
Date of First Enrollment: September 17, 2025
Target Sample Size: 60
To know more, visit https://clinicaltrials.gov/ct2/show/NCT07118215
Published by HT ...